With no known cure and primary characterization of the progressive worsening of symptoms, multiple sclerosis has proved to be one of the hardest diseases to treat. However, patients with MS can draw hope from generally underpublicized research and clinical trials that have shown remarkable improvement in symptoms associated with multiple sclerosis with the use of proteolytic enzymes.
What Is Multiple Sclerosis?
Multiple sclerosis is a disease that involves the progressive disturbance of nerves and typically begins its onset in early adulthood. MS involves a process known as demyelination which is the damage or destruction of myelin, the protective sheath surrounding nerve fibers. The myelin sheath allows communication between the nerve cells, facilitating nerve impulse transmission. Demyelination causes progressive problems with cognition and movement, along with sensory issues. As the myelin sheath continues to be damaged or destroyed around particular nerves, symptoms arise or worsen corresponding to the affected nerves.
Common symptoms of MS include muscle weakness, blurred vision, tingling sensations, dizziness, and other sensory and motor disturbances. The diagnosis of multiple sclerosis can be confirmed using MRI to detect demyelination.
Multiple Sclerosis is a particularly cruel disease in that it involves the worsening of symptoms. With no cure and no current means of reversing the onset of the disease, MS patients continue to seek treatments that will delay the progression of the disease or the onset of worsening symptoms.
Medical practitioners simply aim to trifle with symptoms, alleviate pain, strengthen the patient’s body to prolong movement ability and delay further muscular deterioration, and generally work to provide emotional and physical support and improve the patient’s morale. This lends a sense of hopelessness for those dealing with the disease, with efforts concentrated simply on delaying the inevitable rather than returning the patient to a level of health formally enjoyed.
Understanding Proteolytic Enzymes
Proteolytic enzymes are produced naturally in the pancreas and can also be found in certain foods. Proteolytic enzymes break down protein and are often utilized by people who have difficulty breaking down and digesting proteins naturally. For example, pineapple and papaya are sources of proteolytic enzymes: an understandable source since pineapple and papaya have long been used as natural meat tenderizers. Pineapple contains the proteolytic enzyme bromelain, while papaya contains papain.
While this common use of proteolytic enzymes is now well-established, physicians and scientists around the world are just starting to come to an understanding of how proteolytic enzymes can assist and even heal the body in other ways. A comprehensive 2016 research project showed that bromelain can effectively reduce the growth of tumors and treat inflammation associated with cancer. Similarly, papain has more recently been successfully used to treat muscular pain and aid in muscular recovery, along with specific applications and conditions involving inflammation and pain in the throat, including pharyngitis and tonsillitis.
How Proteolytic Enzymes Can Help Treat MS
A group of physicians based in Europe believe that patients with MS can receive considerable help by proteolytic enzyme treatment. Indeed, this type of treatment is not new – it is simply not a well-known treatment that has been embraced by mainstream medicine.
Most remarkably, scientists and physicians who have been administering proteolytic enzyme treatment to MS patients – often in controlled studies – have seen first-hand how proteolytic enzymes can not only halt the progression of the patient’s disease but alleviate or even dissipate certain symptoms altogether.
One theory to explain the reason why proteolytic enzyme treatment has been so effective when treating Multiple Sclerosis stems from the idea that MS symptoms are worsened by a type of leaky gut condition wherein proteins leak into the bloodstream, causing problematic immune reactions. Since proteolytic enzymes break down protein, they can prove vital in ensuring that this type of leaky gut condition doesn’t occur.
Indeed, regular and timely proteolytic enzyme supplementation can effectively reverse the degenerative nature of MS symptoms.
Evidence from Clinic Trials
An Austrian physician and multiple sclerosis patient, Dr. Christa Neuhofer, treated herself and hundreds of other MS patients with proteolytic enzyme injections for an extensive period spanning more than 20 years. In one of Dr. Neuhofer’s trials involving 43 patients, 35 noticed dramatic improvements in their MS symptoms, in particular in symptoms regarding the bladder, eyes, and rectum. Most remarkably, several participants experienced the complete disappearance of their paralysis.
Dr. Neuhofer also postulated that of those participants who did not experience a dramatic improvement in their symptoms, many had typically previously taken drugs (in particular, Azathioprine) that destroy the body’s immune system. Other participants who didn’t experience symptomatic improvement may not have adhered to the very specific timing requirements of the proteolytic enzyme regime. For example, a delay of even 24 to 48 hours in the administration of proteolytic enzyme injections can dramatically affect the effectiveness of the treatment. In those trials, it was up to the patient to recognize when a new symptom was starting to occur or an existing symptom was becoming exacerbated and then ensuring that their enzyme treatment was administered as promptly as possible.
In another clinical trial, Dr. Anthony Cichoke administered vitamin, mineral, and enzyme supplementation along with a well-balanced diet, detoxification, daily exercise, and stress reduction to effectively treat MS symptoms. Dr. Cichoke similarly reported on the importance of timing when delivering proteolytic enzyme treatments.
Dr. Sedivi from the Hospital of Neurology in the former USSR reported full remission of multiple sclerosis symptoms with a carefully crafted enzyme mixture which included papain and bromelain.
Supplementary Benefits of Proteolytic Enzyme Treatment for Patients with MS
Reduction in Inflammation
The anti-inflammatory nature of proteolytic enzymes can affect all immune complexes, not just myelin. By reducing inflammation in internal organs, blood vessels, tendons, muscles, and the skin and eyes, MS patients can find relief from other symptomatic elements of the disease.
Indeed, a proteolytic enzyme formula created in Germany known as Wobenzyme N has been shown to be more effective at reducing inflammation than corticosteroids, without any risk factors or side-effects.
The anti-inflammatory enzyme serrapeptase – a vital ingredient in Vitalzym products – has been shown to thin inflammatory fluids, prevent excess protein from building up, and drain fluids from areas of inflammation. When looking for a proteolytic enzyme preparation, ensure that the formulation you choose contains a carefully balanced recipe of proteolytic enzymes including serrapeptase, along with antioxidants, plant extracts, and other supplements.
Breaking Down Fibrous Tissue
Proteolytic enzymes can also break down fibrotic tissue, effectively preventing fibrous degeneration, cardiovascular diseases, blood clots, hypertension, and other fibrotic conditions.
Proteolytic enzymes can lower the viscosity of blood, offering blood thinning benefits but without the risk of hemorrhaging or gastrointestinal bleeding. This occurs by way of the breakdown of cellular debris and other waste products within the blood, paving the way for additional white blood cells to provide protection within the bloodstream from unwanted intruders.
Unfortunately, insufficient levels of research into proteolytic enzyme treatment mean that scientists are not yet able to declare a complete victory over multiple sclerosis. However, the resounding successes from the limited clinical trials should be enough evidence to spur further trials and further treatment regimens for MS patients. It remains a shame that the clinical trials and research that have been undertaken thus far has been dramatically under-publicized, leaving the majority of MS patients – and many well-meaning medical practitioners – simply unaware of the benefits of proteolytic enzyme treatment for multiple sclerosis.
At the very least, it is hoped that the successes observed so far can assist those dealing with multiple sclerosis and their families to be hopeful of a chance to alleviate symptoms and achieve a level of health and mobility previously enjoyed, rather than simply delaying the progression of the disease.
Vitalzym products are specially formulated to provide a balanced mix of proteolytic enzymes, antioxidants, and other naturally-occurring ingredients to support the body and provide systematic relief. Find out more about the proven benefits of a balanced multi-enzyme formula.